{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T17:55:14Z","timestamp":1675878914469},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/bf02984567","type":"journal-article","created":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T08:44:12Z","timestamp":1226047452000},"page":"501-505","source":"Crossref","is-referenced-by-count":10,"title":["Relationship between bone scintigraphy and tumor markers in patients with breast cancer"],"prefix":"10.1007","volume":"18","author":[{"given":"Mustafa","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baha","family":"Oral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azem","family":"Cobaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02984567_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","volume":"55","author":"RE Coleman","year":"1987","unstructured":"Coleman RE, Rubens RD. The clinical course of bone metastasis from breast cancer.Br J Cancer 1987; 55:61\u201366.","journal-title":"Br J Cancer"},{"key":"BF02984567_CR2","first-page":"1045","volume":"29","author":"RE Coleman","year":"1988","unstructured":"Coleman RE, Rubens RD, Fogelman I. Reappraisal of the baseline bone scan in breast cancer.J Nucl Med 1988; 29:1045\u20131049.","journal-title":"J Nucl Med"},{"key":"BF02984567_CR3","first-page":"52","volume":"36","author":"F Crippa","year":"1992","unstructured":"Crippa F, Bombardieri E, Seregni M, et al. Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastasis of breast cancer.J Nucl Biol Med 1992; 36:52\u201355.","journal-title":"J Nucl Biol Med"},{"key":"BF02984567_CR4","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/sj.bjc.6690230","volume":"79","author":"A Nicolini","year":"1999","unstructured":"Nicolini A, Ferrari P, Sagripanti A, Carpi A. The role of tumour markers in predicting skeletal metastasis in breast cancer patients with equivocal bone scintigraphy.Br J Cancer 1999; 79:1443\u20131447.","journal-title":"Br J Cancer"},{"key":"BF02984567_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/172460088900400207","volume":"4","author":"? Zanco","year":"1989","unstructured":"Zanco ?, Rota G, Sportiello V, et al. Diagnosis of bone and liver metastasis in breast cancer comparing tumor markers and imaging techniques.Int J Biol Markers 1989; 4:103\u2013105.","journal-title":"Int J Biol Markers"},{"key":"BF02984567_CR6","first-page":"9","volume":"74","author":"DP O\u2019Brien","year":"1992","unstructured":"O\u2019Brien DP, Horgan PG, Gough DB, et al. CA 15-3: a reliable indicator of metastatic bone disease in breast cancer patients.Ann R Coll Surg Engl 1992; 74:9\u201311.","journal-title":"Ann R Coll Surg Engl"},{"key":"BF02984567_CR7","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0959-8049(01)00429-4","volume":"38","author":"R Kokko","year":"2002","unstructured":"Kokko R, Holli K, Hakama M. Ca 15-3 in the follow-up of localised breast cancer: a prospective study.Eur J Cancer 2002;38:1189\u20131193.","journal-title":"Eur J Cancer"},{"issue":"2","key":"BF02984567_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0009-9120(98)00002-2","volume":"31","author":"JC Forest","year":"1998","unstructured":"Forest JC, Masse J, Lane A. Evaluation of the analytical performance of the Boehringer Mannheim Elecsys 2010 immunoanalyzer.Clin Biochem 1998; 31 (2):81\u201388.","journal-title":"Clin Biochem"},{"key":"BF02984567_CR9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/BF01197767","volume":"121","author":"M Koizumi","year":"1995","unstructured":"Koizumi M, Yamada Y, Takiguchi T, et al. Bone metabolic markers in bone metastasis.J Cancer Res Clin Oncol 1995; 121:542\u2013548.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF02984567_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/8756-3282(91)90059-R","volume":"12","author":"M Tubiana-Hulin","year":"1991","unstructured":"Tubiana-Hulin M. Incidence, prevalence and distribution of bone metastasis.Bone 1991; 12:9\u201310.","journal-title":"Bone"},{"key":"BF02984567_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0001-2998(99)80031-2","volume":"29","author":"GJR Cook","year":"1999","unstructured":"Cook GJR, Fogelman I. Skeletal metastasis from breast cancer: Imaging with Nuclear Medicine.Semin Nucl Med 1999; 29:69\u201379.","journal-title":"Semin Nucl Med"},{"key":"BF02984567_CR12","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1200\/JCO.1996.14.10.2843","volume":"14","author":"Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer","year":"1996","unstructured":"Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.J Clin Oncol 1996; 14:2843\u20132877.","journal-title":"J Clin Oncol"},{"key":"BF02984567_CR13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(19910801)68:3<574::AID-CNCR2820680322>3.0.CO;2-B","volume":"68","author":"F Safi","year":"1991","unstructured":"Safi F, Kohler I, Rottinger E, Beger H. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comperative study with carcinoembryonic antigen.Cancer 1991; 68:574\u2013582.","journal-title":"Cancer"},{"key":"BF02984567_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s002590050352","volume":"26","author":"PD Buffaz","year":"1999","unstructured":"Buffaz PD, Gauchez AS, Caravel JP, et al. Can tumor marker assays be a guide in the prescription of bone scan for breast and lung cancers?Eur J Nucl Med 1999; 26:8\u201311.","journal-title":"Eur J Nucl Med"},{"key":"BF02984567_CR15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/172460089701200403","volume":"12","author":"N Younsi","year":"1997","unstructured":"Younsi N, Montravers F, Philippe C, et al. CA 15-3 and bone scintigraphy in the follow-up of breast cancer.Int J Biol Markers 1997; 12:154\u2013157.","journal-title":"Int J Biol Markers"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02984567.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02984567\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02984567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T21:52:11Z","timestamp":1558475531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02984567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["BF02984567"],"URL":"https:\/\/doi.org\/10.1007\/bf02984567","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}